Hepatitis B vaccine immunogenicity in patients with chronic HCV infection at one year follow-up: The effect of interferon-alpha therapy

Medical Science Monitor

Volumn 8, Issue 5, 2002, Pages

  Chlabicz, Sławomir ^a   Grzeszczuk, Anna ^a   Łapiński, Tadeusz Wojciech ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Hepatitis B vaccines; Hepatitis C; Interferon alpha

Indexed keywords

ALPHA INTERFERON; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; RECOMBINANT ALPHA2B INTERFERON; ROPHERON;

ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOGENICITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; SEROPREVALENCE; SEX RATIO; TREATMENT OUTCOME; TREATMENT PLANNING; VACCINATION;

ADULT; AGED; FEMALE; HEPACIVIRUS; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INTERFERON-ALPHA; INTERFERONS; LIVER; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 17444452379     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C
2. The role of hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma
3. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma
4. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus-related chronic liver disease in Japan
5. NIH consensus development conference targets prevention and management of hepatitis C
6. Vaccines to prevent viral hepatitis
7. Response to hepatitis B vaccination in patients with severe liver disease: Absence of an HLA effect
8. Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: A randomized clinical trial
9. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C
10. Hepatitis B virus vaccine for patients with hepatitis C virus infection
11. Hepatitis B vaccination in patients with chronic hepatitis C
12. Classification of chronic viral hepatitis: A need for reassessment
13. Recombinant hepatitis B vaccine immunogenicity, in the presence of hepatitis C virus seropositivity
14. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease
15. Hepatitis B vaccination of patients with chronic liver disease
16. Antibody level after hepatitis B vaccination in hemodialysis patients: Influence of hepatitis C virus infection
17. Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in hemodialysis patients
18. Improving the response to hepatitis B vaccine
19. Is nonresponsiveness to hepatitis 13 vaccine due to latent hepatitis B infection?
20. Occult hepatitis B infection in patients with chronic hepatitis C liver disease
21. Antibody response to hepatitis B virus vaccination in individuals with hepatitis C virus infection
22. Are booster immunisations needed for lifelong hepatitis B immunity?
23. Antibody response to hepatitis B virus vaccination in individuals with hepatitis C virus infection
24. Randomized comparative trial of interferon-α versus placebo in hepatitis B vaccine non-responders and hyporesponders
25. Interferon as an adjuvant for hepatitis B vaccination in non- and low-responder populations
26. The effect of alpha interferon therapy and short-interval intradermal administration on response to hepatitis B vaccine in hemodialysis patients
27. Recombinant gamma-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients